Anti-rhesus d human monoclonal antibodies

EP4766736A1Pending Publication Date: 2026-07-01THE WALTER AND ELIZA HALL INSTITUTE OF MEDECAL RESEARCH +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
THE WALTER AND ELIZA HALL INSTITUTE OF MEDECAL RESEARCH
Filing Date
2024-08-23
Publication Date
2026-07-01

Smart Images

  • Figure IMGF000028_0001
    Figure IMGF000028_0001
  • Figure IMGF000029_0001
    Figure IMGF000029_0001
  • Figure IMGF000030_0001
    Figure IMGF000030_0001
Patent Text Reader

Abstract

The present invention provides for recombinant antibodies which bind to RhD blood group antigens as well as compositions comprises these recombinant antibodies and methods for selecting a combination of different recombinant antibodies derived from donor blood. The recombinant antibodies are useful for the treatment of the prevention of haemolytic disease of the newborn (HDN), treatment of idiopathic thrombocytopenic purpura (ITP), and to impede anti-RhD alloimmunisation in RhD negative patients who receive an RhD+ blood transfusion.
Need to check novelty before this filing date? Find Prior Art